KSS
39
-7
SWK
50
-5
RHI
57
-6
AVGO
18
-9
AZO
50
-5
TSCO
44
-4
XEL
67
2
OI
42
-3
ADBE
47
-9
ORLY
60
-5
KIM
72
2
MO
60
-2
SHW
62
-6
M
31
-3
DE
42
3
WEC
53
5
EXR
57
2
COF
62
3
UPS
48
2
SYF
86
-6
KSS
39
-7
SWK
50
-5
RHI
57
-6
AVGO
18
-9
AZO
50
-5
TSCO
44
-4
XEL
67
2
OI
42
-3
ADBE
47
-9
ORLY
60
-5
KIM
72
2
MO
60
-2
SHW
62
-6
M
31
-3
DE
42
3
WEC
53
5
EXR
57
2
COF
62
3
UPS
48
2
SYF
86
-6
Financhill
Back

Swiss Helvetia Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
52

SWZ
Swiss Helvetia Fund

Last Price:
7.88
Seasonality Move:
0.79%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Buy
52
Swiss Helvetia Fund (SWZ) is a Buy

Is Swiss Helvetia Fund a Buy, Sell or Hold?

  • The current Swiss Helvetia Fund [SWZ] share price is $7.87. The Score for SWZ is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SWZ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SWZ Stock Price Chart

What is Swiss Helvetia Fund's stock price today?

  • The Swiss Helvetia Fund share price today is $7.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWZ is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SWZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 26.27 Sell
Chaikin Money Flow: -4994 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.03 - 8.57) Sell
Bollinger Bands (100): (8.23 - 8.83) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SWZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8 Sell
20-day SMA: 8.2 Sell
50-day SMA: 8.57 Sell
200-day SMA: 8.21 Sell
8-day EMA: 7.99 Sell
20-day EMA: 8.18 Sell
50-day EMA: 8.41 Sell
200-day EMA: 8.3 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Swiss Helvetia Fund Earnings Growth & SWZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Swiss Helvetia Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):